Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2023.1244340 Cardiovascular Medicine Correction Corrigendum: The rationale for the treatment of long-COVID esymptoms—a cardiologist's view SchiefferElisabeth SchiefferBernhard * Department of Cardiology, Angiology and Critical Care Medicine, University Hospital Marburg (UKGM), Philipps University Marburg, Marburg, Germany

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 Correspondence: Bernhard Schieffer Bernhard.Schieffer@staff.uni-marburg.de 21072023 2023 101244340 22062023 22062023 © 2023 Schieffer and Schieffer. 2023Schieffer and Schieffer

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 lipid – hybrid nanoparticles HDL - cholesterol long-Covid syndrome histamin challenge cholesterol renin-angiotensin system kalkrein-kinin system section-at-acceptanceLipids in Cardiovascular Disease A Corrigendum on The rationale for the treatment of long-COVID symptoms—a cardiologist’s view By Schieffer E and Schieffer B. (2022) Front Cardiovasc Med. 9:992686. doi: 10.3389/fcvm.2022.992686

In the published article, there was an error in the article type. It was incorrectly published as a Systematic Review. The correct article type is: Perspective.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.